Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Group entities : Aptorum group limited save search
Aptorum Group Receives Nasdaq Approval to Transfer Listing to Nasdaq Capital Markets
Published: 2023-08-10 (Crawled : 09:00) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: 3.54%
H: 1.95%
C: -5.86%
nasdaq transfer approval group
Aptorum Group Updates on a Phase 1b/2a Clinical Trial for Repurposed Small Molecule Drug SACT-1 for Neuroblastoma
Published: 2023-06-22 (Crawled : 13:00) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: 0.73%
H: 0.36%
C: -1.81%
drug repurposed group trial
Aptorum Group Announces Completion of Pre-IND Discussions with US FDA on its ALS-4, a First-in-Class Small Molecule Drug Targeting Methicillin Resistant Staphylococcus Aureus
Published: 2023-03-03 (Crawled : 14:00) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.23%
fda drug group staphylococcus aureus
Aptorum Group Announces Completion of End of Phase 1 (EOP1) Meeting with US FDA on its SACT-1, a Repurposed Small Molecule Drug Targeting Neuroblastoma
Published: 2023-03-03 (Crawled : 14:00) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.23%
fda drug meeting repurposed group phase 1
Aptorum Group Announces 1-for-10 Reverse Stock Split
Published: 2023-01-20 (Crawled : 14:00) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: -3.51%
H: 18.18%
C: 1.82%
group
Aptorum Group Limited Announces Results of 2022 Annual General Meeting of Shareholders
Published: 2022-12-22 (Crawled : 13:20) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: 4.95%
H: 10.92%
C: 2.25%
meeting results group
Aptorum Group Announces Offering of $3 Million Convertible Note due 2023
Published: 2022-12-09 (Crawled : 13:00) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: -16.14%
H: 19.24%
C: 14.67%
offering group
Aptorum Group Updates on the Clinical Validation of RPIDD Infectious Disease Liquid Biopsy Molecular Diagnostics
Published: 2022-09-15 (Crawled : 14:00) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: 2.07%
H: 6.08%
C: 3.38%
disease diagnostics molecular group
Aptorum Group Limited to Present at the H.C. Wainwright Annual Global Investment Conference, September 13-16, 2022
Published: 2022-08-26 (Crawled : 05:00) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: -1.29%
H: 3.18%
C: -6.59%
global group
Aptorum Group Limited to Present at the H.C. Wainwright Global Investment Conference, May 23 – 26 2022
Published: 2022-05-17 (Crawled : 13:20) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: 0.0%
H: 7.65%
C: 5.71%
group
Aptorum Group Updates on Data from the Completed Phase 1 Clinical Trial of SACT-1, targeting neuroblastoma
Published: 2022-05-02 (Crawled : 12:20) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: 8.65%
H: 0.0%
C: -11.5%
trial group phase 1
Aptorum Group Receives FDA Orphan Drug Designation for its SACT-1 Repurposed Drug For The Treatment of Neuroblastoma
Published: 2022-01-20 (Crawled : 13:30) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: 29.51%
H: 10.13%
C: 6.96%
treatment fda drug orphan drug repurposed group designation
Aptorum Group Granted The First Patent for its SACT-1 Repurposed Drug For Treatment of Various Cancer Including but Not Limited to Neuroblastoma
Published: 2022-01-18 (Crawled : 13:30) - biospace.com/
APM | $5.59 -22.9% -29.93% 120K
|
Health Technology
|
| O: -0.75%
H: 5.3%
C: -3.79%
treatment drug patent granted cancer repurposed group
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.